Donaldson acquires bioprocessing and filtration company Solaris
In November 2021, Donaldson Company acquired Italian bioprocessing company Solaris for approximately 41 million EUR. Solaris produces bioreactors and tangential flow filtration systems, which provide an efficient way of separating and purifying biomolecules. The company built strong research and development platforms and manufactured early-stage systems for commercial use. With the addition of Solaris, Donaldson can expand into food, beverage and bio-pharmaceutical markets. Solaris’ estimated 2021 revenue of 5 million EUR, or $5.5 billion, adds to Donaldson’s $2.8 billion in 2021 revenue. Donaldson gains more from Solaris’ product portfolio, talented workforce and market expertise.
M&AIn response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.
Lorem Ipsum text header Report Title
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.
Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.